APA citiranje

Takahashi, S., Fujiwara, Y., Nakano, K., Shimizu, T., Tomomatsu, J., Koyama, T., . . . Yamamoto, N. (2021). Safety and pharmacokinetics of milademetan, a MDM2 inhibitor, in Japanese patients with solid tumors: A phase I study. Cancer Sci.

Citação norma Chicago

Takahashi, Shunji, et al. "Safety and Pharmacokinetics of Milademetan, a MDM2 Inhibitor, in Japanese Patients With Solid Tumors: A Phase I Study." Cancer Sci 2021.

MLA citiranje

Takahashi, Shunji, et al. "Safety and Pharmacokinetics of Milademetan, a MDM2 Inhibitor, in Japanese Patients With Solid Tumors: A Phase I Study." Cancer Sci 2021.